HIV Infections
Showing NaN - NaN of 736
HIV, Sexually Transmitted Diseases, Viral, Syphilis Trial in New York, Nashville (mLab App Plus)
Recruiting
- HIV Infections
- +2 more
- mLab App Plus
-
New York, New York
- +1 more
Sep 22, 2023
HIV Trial in Puerto Rico, United States (VH3810109, Cabotegravir, Standard of care (SOC))
Not yet recruiting
- HIV Infections
- VH3810109
- +3 more
-
Birmingham, Alabama
- +42 more
Aug 9, 2023
HIV Trial in Ann Arbor, New York (Couples HIV testing and counseling, Individual HIV testing and counseling)
Enrolling by invitation
- HIV Infections
- Couples HIV testing and counseling
- Individual HIV testing and counseling
-
Ann Arbor, Michigan
- +1 more
Apr 17, 2023
HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)
Suspended
- HIV Infections
- BG505 MD39.3 mRNA
- +2 more
-
Birmingham, Alabama
- +9 more
Feb 1, 2023
Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)
Recruiting
- Hepatitis B
- HIV Infections
- Selgantolimod
- Placebo
-
San Diego, California
- +35 more
Jan 31, 2023
HIV Trial in United States (PGT121.414.LS, VRC07-523LS)
Completed
- HIV Infections
- PGT121.414.LS
- VRC07-523LS
-
Los Angeles, California
- +4 more
Jan 31, 2023
HIV Trial in Canada, United States (CAB LA, RPV LA, RPV)
Active, not recruiting
- HIV Infections
- CAB LA
- +3 more
-
Phoenix, Arizona
- +29 more
Jan 22, 2023
HIV, HIV-1 Trial in Worldwide (Etravirine)
Active, not recruiting
- HIV Infections
- HIV-1
-
Los Angeles, California
- +30 more
Jan 17, 2023
Consent for Use of Stored Patient Specimens for Future Testing
Recruiting
- HIV Infections
-
Los Angeles, California
- +62 more
Dec 7, 2022
Smoking Cessation, HIV Trial in New York (Sense2Quit App)
Recruiting
- Smoking Cessation
- HIV Infections
- Sense2Quit App
-
New York, New YorkColumbia University Irving Medical Center
Nov 4, 2022
HIV Trial in New York (CARE+ Spanish computer counseling session, CARE+ Spanish brief computer risk assessment session)
Completed
- HIV Infections
- CARE+ Spanish computer counseling session
- CARE+ Spanish brief computer risk assessment session
-
New York, New YorkSt. Luke's Roosevelt
Oct 26, 2022
HIV Trial in New York (Care Navigator, Health Information Supported Ending the HIV Epidemic (ETE) Activities in Dental Setting)
Recruiting
- HIV Infections
- Care Navigator
- Health Information Supported Ending the HIV Epidemic (ETE) Activities in Dental Setting
-
New York, New York
- +1 more
Oct 14, 2022
Lipodystrophy, HIV Trial in Worldwide (Tesamorelin, Placebo for Tesamorelin)
Completed
- Lipodystrophy
- HIV Infections
- Tesamorelin
- Placebo for Tesamorelin
-
Birmingham, Alabama
- +46 more
Sep 16, 2022
HIV Trial in Chicago, New York (mLab App, HIV Prevention Information, HIV Home Tests)
Active, not recruiting
- HIV Infections
- mLab App
- +2 more
-
Chicago, Illinois
- +1 more
Sep 21, 2022
The Women's HIV SeroIncidence Study (ISIS)
Completed
- HIV Infections
-
Washington, District of Columbia
- +8 more
Aug 25, 2022
Acquired Immune Deficiency Syndrome (AIDS), HIV Trial in Worldwide (ATV, DRV, Cobicistat)
Recruiting
- Acquired Immune Deficiency Syndrome (AIDS)
- HIV Infections
- ATV
- +3 more
-
Long Beach, California
- +29 more
Aug 18, 2022
HIV, Renal Transplant Rejection Trial in New York (BIKTARVY 50Mg-200Mg-25Mg Tablet)
Recruiting
- HIV Infections
- Renal Transplant Rejection
- BIKTARVY 50Mg-200Mg-25Mg Tablet
-
New York, New YorkWeill Cornell Medicine
Aug 1, 2022
HIV Trial in New York (Youth Health SMS)
Not yet recruiting
- HIV Infections
- Youth Health SMS
-
New York, New YorkNew York State Psychiatric Institute
Jul 30, 2022
Antiretroviral Drugs and Related Drugs During and After
HIV Trial in New York (CPS, SMS)
Completed
- HIV Infections
- CPS
- SMS
-
New York, New YorkThe City University of New York
Jul 5, 2022
HIV Trial in United States (MPER-656 Liposome Vaccine, Placebo for MPER-656 Liposome Vaccine)
Completed
- HIV Infections
- MPER-656 Liposome Vaccine
- Placebo for MPER-656 Liposome Vaccine
-
Birmingham, Alabama
- +5 more
Jun 15, 2022
HIV, Cytomegalovirus, CMV Trial in United States (Letermovir 240 MG Oral Tablet, Letermovir 480 MG Oral Tablet, Combination ART)
Recruiting
- HIV Infections
- +2 more
- Letermovir 240 MG Oral Tablet
- +2 more
-
Birmingham, Alabama
- +18 more
Jun 20, 2022
HIV, Acquired Immune Deficiency Syndrome, Sexually Transmitted Diseases, Viral Trial in New York, La Romana (WiseApp)
Recruiting
- HIV Infections
- +2 more
- WiseApp
-
New York, New York
- +1 more
May 25, 2022
HIV Trial in Worldwide (Placebo for maraviroc (MVC), Placebo for dolutegravir (DTG), Dolutegravir (DTG))
Completed
- HIV Infections
- Placebo for maraviroc (MVC)
- +3 more
-
Los Angeles, California
- +29 more
Apr 20, 2022